Initial Management of Angina Pectoris
For patients presenting with chest discomfort suggestive of angina pectoris, obtain a 12-lead ECG within 10 minutes of arrival, measure cardiac-specific troponin immediately, and initiate aspirin 75-325 mg unless contraindicated. 1, 2
Immediate Assessment (First 10 Minutes)
Critical Actions
- Perform 12-lead ECG within 10 minutes and compare to prior tracings if available to differentiate ST-elevation MI (requiring immediate reperfusion) from non-ST-elevation acute coronary syndrome 1, 3
- Place patient on continuous cardiac monitoring with defibrillator nearby, as sudden ventricular fibrillation is the major preventable cause of early death 1, 2
- Measure cardiac-specific troponin (preferred over CK-MB or other markers) as the initial biomarker 1
- Administer aspirin 75-325 mg immediately (chewed for faster absorption) unless contraindicated 1, 2
Symptom Relief
- Give sublingual nitroglycerin 0.4 mg every 5 minutes for up to 3 doses for immediate symptom relief 2, 4
- If chest pain persists after 3 tablets over 15 minutes, this indicates high-risk acute coronary syndrome requiring hospital admission 1, 4
- Administer supplemental oxygen only if arterial saturation <90% confirmed by pulse oximetry 1, 3, 2
Risk Stratification (Within First Hour)
High-Risk Features Requiring Immediate Hospital Admission
Patients with any of the following must be admitted to the hospital immediately 1:
- Ongoing chest pain despite nitroglycerin (>20 minutes duration)
- ST-segment depression ≥0.05 mV or T-wave inversions ≥0.2 mV on ECG 1
- Elevated cardiac troponin levels (indicating NSTEMI rather than unstable angina) 1
- Hemodynamic instability (hypotension, new heart failure, pulmonary edema) 1, 2
- Major arrhythmias (repetitive ventricular tachycardia, ventricular fibrillation) 1
- Diabetes mellitus with any ischemic symptoms 1
Intermediate/Low-Risk Features Requiring Observation
Patients who are pain-free at presentation, have normal or nondiagnostic ECG, and normal initial troponin are candidates for observation in a chest pain unit or emergency department 1:
- Repeat ECG at 15-30 minute intervals if patient remains symptomatic or high clinical suspicion persists 1
- Repeat troponin measurement at 6-12 hours after symptom onset (not just after arrival) 1
- Observation period typically 6-12 hours but may extend to 24 hours depending on institutional protocols 1
Pharmacological Management for Confirmed ACS
Antiplatelet Therapy
- Continue aspirin 75-150 mg daily indefinitely 1, 2
- Add clopidogrel loading dose 300-600 mg, then 75 mg daily for 12 months 3, 2
- Consider ticagrelor as preferred P2Y12 inhibitor for moderate-to-high risk patients 3
Anticoagulation (Choose One)
- Enoxaparin 1 mg/kg subcutaneously every 12 hours (preferred for conservative management, lower risk of heparin-induced thrombocytopenia) 2
- Fondaparinux 2.5 mg subcutaneously once daily (associated with less bleeding than enoxaparin) 2
- Unfractionated heparin (if early invasive strategy planned) 1, 2
Anti-Ischemic Therapy
- Start oral beta-blocker promptly targeting heart rate 50-60 beats per minute unless contraindicated 1, 2
- Initiate intravenous nitroglycerin 5-10 mcg/min for ongoing ischemia or hypertension, titrating by 10 mcg/min every 3-5 minutes 2
- Add calcium channel blocker (dihydropyridine family) if symptoms persist despite beta-blocker and nitrates 1
Additional Mortality-Reducing Therapies
- Initiate high-intensity statin therapy immediately regardless of baseline LDL cholesterol 3, 2
- Start ACE inhibitor if patient has anterior MI, persistent hypertension, left ventricular dysfunction, heart failure, or diabetes 2
Disposition Decision Algorithm
Discharge Criteria (After Observation Period)
Patients may be discharged if all of the following are met 1:
- Pain-free throughout observation period
- Normal or unchanged ECG on serial tracings
- Normal cardiac biomarkers at 6-12 hours after symptom onset
- Negative stress test (treadmill, stress echo, or nuclear imaging) performed before discharge or within 72 hours as outpatient 1
Admission Criteria
Admit to hospital if any of the following develop during observation 1:
- Recurrent ischemic chest discomfort
- New ECG abnormalities on follow-up tracings
- Elevated cardiac biomarkers on repeat measurement
- Hemodynamic abnormalities (new or worsening heart failure)
- Positive stress test 1
Common Pitfalls to Avoid
- Do not rely on traditional CAD risk factors (age, smoking, hyperlipidemia) to determine admission versus discharge—symptoms, ECG, and troponin are far more important 1
- Do not discharge patients with normal initial troponin without waiting 6-12 hours from symptom onset, as troponin may not rise immediately 1
- Do not use total CK, AST, ALT, or LDH as primary tests for myocardial injury—cardiac-specific troponin is mandatory 1
- Do not assume nitroglycerin-responsive pain excludes ACS—many non-cardiac causes also respond to nitrates 4
- Avoid excessive nitroglycerin use as tolerance can develop with continuous high-dose administration 4
- Do not combine nitroglycerin with PDE-5 inhibitors (sildenafil, tadalafil, vardenafil) as severe hypotension may result 4